The emergence of SARS-CoV-2 variants has raised concerns about the effectiveness of existing COVID-19 vaccines. Some variants have shown reduced susceptibility to antibodies generated by vaccination. However, vaccines still offer substantial protection against severe disease and death caused by these variants. Ongoing research and potential updates to vaccines aim to address these challenges.
